Destiny Pharma plc

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Infectious diseases, therapeutics and prophylactics
Ticker:
DEST
Exchange:
LSE AIM
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United Kingdom
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
NTCD-M3 & XF-73 Nasal
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
Chief Business Officer
Destiny Pharma plc